Publication Information

{'id': 'https://openalex.org/W2144829413', 'doi': 'https://doi.org/10.1258/095646207780749790', 'title': 'Discontinuation of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy due to nucleoside analogue reverse transcriptase inhibitor-related metabolic toxicity', 'display_name': 'Discontinuation of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy due to nucleoside analogue reverse transcriptase inhibitor-related metabolic toxicity', 'publication_year': 2007, 'publication_date': '2007-05-01', 'ids': {'openalex': 'https://openalex.org/W2144829413', 'doi': 'https://doi.org/10.1258/095646207780749790', 'mag': '2144829413', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/17524198'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1258/095646207780749790', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30045969', 'display_name': 'International Journal of STD & AIDS', 'issn_l': '0956-4624', 'issn': ['0956-4624', '1758-1052'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320017', 'host_organization_name': 'SAGE Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320017'], 'host_organization_lineage_names': ['SAGE Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5074817491', 'display_name': 'Lewis Haddow', 'orcid': 'https://orcid.org/0000-0003-3016-2986'}, 'institutions': [{'id': 'https://openalex.org/I60488453', 'display_name': 'Middlesex University', 'ror': 'https://ror.org/01rv4p989', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I60488453']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'L J Haddow', 'raw_affiliation_strings': ['Coleridge Unit, North Middlesex University Hospital NHS Trust, Silver Street, Edmonton, London N18 1QX, UK.'], 'affiliations': [{'raw_affiliation_string': 'Coleridge Unit, North Middlesex University Hospital NHS Trust, Silver Street, Edmonton, London N18 1QX, UK.', 'institution_ids': ['https://openalex.org/I60488453']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108525697', 'display_name': 'Chris Wood', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I60488453', 'display_name': 'Middlesex University', 'ror': 'https://ror.org/01rv4p989', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I60488453']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'C W Wood', 'raw_affiliation_strings': ['Coleridge Unit, North Middlesex University Hospital NHS Trust, Silver Street, Edmonton, London N18 1QX, UK.'], 'affiliations': [{'raw_affiliation_string': 'Coleridge Unit, North Middlesex University Hospital NHS Trust, Silver Street, Edmonton, London N18 1QX, UK.', 'institution_ids': ['https://openalex.org/I60488453']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5110200525', 'display_name': 'Jonathan Ainsworth', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I60488453', 'display_name': 'Middlesex University', 'ror': 'https://ror.org/01rv4p989', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I60488453']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'J G Ainsworth', 'raw_affiliation_strings': ['Coleridge Unit, North Middlesex University Hospital NHS Trust, Silver Street, Edmonton, London N18 1QX, UK.'], 'affiliations': [{'raw_affiliation_string': 'Coleridge Unit, North Middlesex University Hospital NHS Trust, Silver Street, Edmonton, London N18 1QX, UK.', 'institution_ids': ['https://openalex.org/I60488453']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.323, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 6, 'citation_normalized_percentile': {'value': 0.552297, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 79, 'max': 80}, 'biblio': {'volume': '18', 'issue': '5', 'first_page': '343', 'last_page': '346'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10112', 'display_name': 'HIV Research and Treatment', 'score': 0.9989, 'subfield': {'id': 'https://openalex.org/subfields/2406', 'display_name': 'Virology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11655', 'display_name': 'HIV-related health complications and treatments', 'score': 0.9983, 'subfield': {'id': 'https://openalex.org/subfields/2711', 'display_name': 'Emergency Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/lipodystrophy', 'display_name': 'Lipodystrophy', 'score': 0.8386551}, {'id': 'https://openalex.org/keywords/discontinuation', 'display_name': 'Discontinuation', 'score': 0.8275244}, {'id': 'https://openalex.org/keywords/reverse-transcriptase-inhibitor', 'display_name': 'Reverse-transcriptase inhibitor', 'score': 0.7320534}, {'id': 'https://openalex.org/keywords/mitochondrial-toxicity', 'display_name': 'Mitochondrial toxicity', 'score': 0.71010673}, {'id': 'https://openalex.org/keywords/regimen', 'display_name': 'Regimen', 'score': 0.6117057}, {'id': 'https://openalex.org/keywords/lipoatrophy', 'display_name': 'Lipoatrophy', 'score': 0.6018911}, {'id': 'https://openalex.org/keywords/nucleoside-analogue', 'display_name': 'Nucleoside analogue', 'score': 0.5947464}, {'id': 'https://openalex.org/keywords/didanosine', 'display_name': 'Didanosine', 'score': 0.546888}, {'id': 'https://openalex.org/keywords/stavudine', 'display_name': 'Stavudine', 'score': 0.47544098}, {'id': 'https://openalex.org/keywords/drug-holiday', 'display_name': 'Drug holiday', 'score': 0.4267534}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8608659}, {'id': 'https://openalex.org/C2780941825', 'wikidata': 'https://www.wikidata.org/wiki/Q1538213', 'display_name': 'Lipodystrophy', 'level': 5, 'score': 0.8386551}, {'id': 'https://openalex.org/C2778715236', 'wikidata': 'https://www.wikidata.org/wiki/Q55622662', 'display_name': 'Discontinuation', 'level': 2, 'score': 0.8275244}, {'id': 'https://openalex.org/C2909970146', 'wikidata': 'https://www.wikidata.org/wiki/Q421559', 'display_name': 'Nucleoside Reverse Transcriptase Inhibitor', 'level': 5, 'score': 0.7454337}, {'id': 'https://openalex.org/C2777351918', 'wikidata': 'https://www.wikidata.org/wiki/Q421559', 'display_name': 'Reverse-transcriptase inhibitor', 'level': 5, 'score': 0.7320534}, {'id': 'https://openalex.org/C2777071529', 'wikidata': 'https://www.wikidata.org/wiki/Q12796879', 'display_name': 'Mitochondrial toxicity', 'level': 3, 'score': 0.71010673}, {'id': 'https://openalex.org/C2781413609', 'wikidata': 'https://www.wikidata.org/wiki/Q7308373', 'display_name': 'Regimen', 'level': 2, 'score': 0.6117057}, {'id': 'https://openalex.org/C2779546735', 'wikidata': 'https://www.wikidata.org/wiki/Q3500973', 'display_name': 'Lipoatrophy', 'level': 5, 'score': 0.6018911}, {'id': 'https://openalex.org/C2777333352', 'wikidata': 'https://www.wikidata.org/wiki/Q2689559', 'display_name': 'Nucleoside analogue', 'level': 3, 'score': 0.5947464}, {'id': 'https://openalex.org/C29730261', 'wikidata': 'https://www.wikidata.org/wiki/Q274160', 'display_name': 'Toxicity', 'level': 2, 'score': 0.5929589}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5805102}, {'id': 'https://openalex.org/C2777447569', 'wikidata': 'https://www.wikidata.org/wiki/Q422606', 'display_name': 'Didanosine', 'level': 5, 'score': 0.546888}, {'id': 'https://openalex.org/C2779889181', 'wikidata': 'https://www.wikidata.org/wiki/Q423984', 'display_name': 'Stavudine', 'level': 5, 'score': 0.47544098}, {'id': 'https://openalex.org/C72563966', 'wikidata': 'https://www.wikidata.org/wiki/Q1303415', 'display_name': 'Cohort', 'level': 2, 'score': 0.46494618}, {'id': 'https://openalex.org/C140206745', 'wikidata': 'https://www.wikidata.org/wiki/Q5308895', 'display_name': 'Drug holiday', 'level': 3, 'score': 0.4267534}, {'id': 'https://openalex.org/C142462285', 'wikidata': 'https://www.wikidata.org/wiki/Q2528140', 'display_name': 'Viral load', 'level': 3, 'score': 0.40637165}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.36845186}, {'id': 'https://openalex.org/C2993143319', 'wikidata': 'https://www.wikidata.org/wiki/Q583050', 'display_name': 'Antiretroviral therapy', 'level': 4, 'score': 0.3452012}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.25079292}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.23631307}, {'id': 'https://openalex.org/C2776543447', 'wikidata': 'https://www.wikidata.org/wiki/Q28734', 'display_name': 'Nucleoside', 'level': 2, 'score': 0.18006936}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.06273654}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D023241', 'descriptor_name': 'Antiretroviral Therapy, Highly Active', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D019829', 'descriptor_name': 'Nevirapine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D000293', 'descriptor_name': 'Adolescent', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000480', 'descriptor_name': 'Alkynes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D023241', 'descriptor_name': 'Antiretroviral Therapy, Highly Active', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': False}, {'descriptor_ui': 'D023241', 'descriptor_name': 'Antiretroviral Therapy, Highly Active', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D048588', 'descriptor_name': 'Benzoxazines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D048588', 'descriptor_name': 'Benzoxazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018791', 'descriptor_name': 'CD4 Lymphocyte Count', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015331', 'descriptor_name': 'Cohort Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003521', 'descriptor_name': 'Cyclopropanes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004334', 'descriptor_name': 'Drug Administration Schedule', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D064420', 'descriptor_name': 'Drug-Related Side Effects and Adverse Reactions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019829', 'descriptor_name': 'Nevirapine', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D019829', 'descriptor_name': 'Nevirapine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': 'Q000145', 'qualifier_name': 'classification', 'is_major_topic': False}, {'descriptor_ui': 'D006113', 'descriptor_name': 'United Kingdom', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1258/095646207780749790', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30045969', 'display_name': 'International Journal of STD & AIDS', 'issn_l': '0956-4624', 'issn': ['0956-4624', '1758-1052'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320017', 'host_organization_name': 'SAGE Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320017'], 'host_organization_lineage_names': ['SAGE Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/17524198', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.83}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 11, 'referenced_works': ['https://openalex.org/W1985646480', 'https://openalex.org/W1989206970', 'https://openalex.org/W2020845967', 'https://openalex.org/W2041841997', 'https://openalex.org/W2056118379', 'https://openalex.org/W2063329141', 'https://openalex.org/W2110937228', 'https://openalex.org/W2117261241', 'https://openalex.org/W2141776019', 'https://openalex.org/W2330914362', 'https://openalex.org/W2333399282'], 'related_works': ['https://openalex.org/W4235354421', 'https://openalex.org/W4234771441', 'https://openalex.org/W2460435783', 'https://openalex.org/W2333547784', 'https://openalex.org/W2101615600', 'https://openalex.org/W2023419369', 'https://openalex.org/W2019894676', 'https://openalex.org/W1975492163', 'https://openalex.org/W1963888230', 'https://openalex.org/W1577104482'], 'abstract_inverted_index': {'We': [0], 'aimed': [1], 'to': [2, 106, 146], 'evaluate': [3], 'the': [4, 127], 'reasons': [5, 74, 90, 96], 'for,': [6], 'and': [7, 38, 62, 94, 114], 'timing': [8], 'of,': [9], 'treatment': [10], 'changes': [11], 'in': [12, 69, 80, 86, 91, 97, 120, 135, 153], 'a': [13, 67], 'cohort': [14, 137], 'of': [15, 141], 'treatment-naïve': [16], 'patients': [17, 31, 59, 64, 82, 101, 121], 'initiating': [18, 32], 'non-nucleoside': [19], 'reverse': [20], 'transcriptase': [21], 'inhibitor': [22], '(NNRTI)-containing': [23], 'highly': [24], 'active': [25], 'antiretroviral': [26], 'therapy': [27], '(HAART).': [28], 'All': [29], '268': [30], 'these': [33, 115], 'regimens': [34], 'between': [35], 'January': [36], '1998': [37], 'September': [39], '2003': [40], 'were': [41, 76, 117], 'included.': [42], 'Median': [43], 'follow': [44], 'up': [45], 'was': [46, 54, 143], '103': [47], 'weeks.': [48], 'The': [49, 73, 133], 'median': [50, 128], 'baseline': [51, 123, 157], 'CD4': [52, 124, 158], 'count': [53, 125], '150': [55], 'cells/': [56], 'μL.': [57], 'Seven': [58], '(3%)': [60], 'died': [61], '155': [63], '(58%)': [65], 'experienced': [66], 'change': [68], 'their': [70], 'HAART': [71, 142], 'regimen.': [72], 'drugs': [75], 'discontinued': [77], 'included': [78], 'toxicity': [79, 152], '106': [81], '(40%),': [83], 'virological': [84], 'failure': [85], '21': [87], '(8%),': [88], 'other': [89], '23': [92], '(9%)': [93], 'unknown': [95], 'five': [98], '(2%).': [99], 'Fifty-one': [100], '(19%)': [102], 'stopped': [103], 'NRTIs': [104], 'due': [105, 145], 'peripheral': [107], 'neuropathy,': [108], 'hyperlactataemia,': [109], 'lipoatrophy,': [110], 'lipodystrophy': [111], 'or': [112, 150], 'myelosuppression,': [113], 'events': [116], 'more': [118], 'likely': [119], 'with': [122, 155], 'below': [126], '(': [129], 'P': [130], '=': [131], '0.039).': [132], 'findings': [134], 'this': [136], 'show': [138], 'that': [139], 'discontinuation': [140], 'commonly': [144], 'toxicity,': [147], 'especially': [148], 'metabolic': [149], 'mitochondrial': [151], 'those': [154], 'lower': [156], 'count.': [159]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2144829413', 'counts_by_year': [{'year': 2013, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-10T08:36:42.140575', 'created_date': '2016-06-24'}